Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse

O Prause1, S Bozinovski, G P Anderson

  • 1Lung Pharmacology Group, Department of Respiratory Medicine and Allergology, Institute of Internal Medicine, Göteborg University, Gothenburg, Sweden. olof.prause@lungall.gu.se

Thorax
|March 30, 2004
PubMed
Abstract

Insights

Interleukin-17 (IL-17) increases active matrix metalloproteinase-9 (MMP-9) in mouse airways, primarily by recruiting more neutrophils. This suggests a link between IL-17 and airway remodeling in severe asthma and COPD.

Area of Science:

  • Pulmonary immunology
  • Protease biology

Background:

  • Matrix metalloproteinase (MMP)-9 degrades airway extracellular matrix.
  • MMP-9 is implicated in airway remodeling in severe asthma and COPD.

Purpose of the Study:

  • To investigate the effect of interleukin (IL)-17 on MMP-9 release and activity in airways.

Main Methods:

  • In vivo intranasal stimulation of mice with IL-17.
  • In vitro stimulation of mouse neutrophils with IL-17.
  • Analysis of MMP-9 precursor (proMMP-9) and active MMP-9 in bronchoalveolar lavage (BAL) fluid.
  • Neutrophil quantification and MMP-9 staining.

Main Results:

  • IL-17 induced proMMP-9 release and active MMP-9 in mouse BAL fluid.
  • IL-17 increased neutrophil accumulation, correlating with MMP-9 levels.
  • MMP-9 levels per neutrophil did not increase; in vitro neutrophil stimulation with IL-17 did not enhance proMMP-9 release.

Conclusions:

  • Local IL-17 stimulation increases active MMP-9 and its precursor in mouse airways.
  • Increased MMP-9 is mainly due to neutrophil recruitment, not enhanced release per neutrophil.
  • IL-17 links to increased airway proteolytic load, relevant to severe asthma and COPD.